novo nordisk glp-1 receptor agonist said on Tuesday its triple UBT251 of the receptors for GLP-1, GIP and glucagon, jointly developed with United Biotechnology, achieved a statistically significant mean weight loss of up to GLP-1 and the kidney: from
Description
& Weiss, J
Since GLP-1 is prone to degradation by dipeptidyl peptidase 4, GLP-1 receptor agonists (GLP-1RAs) have been developed to surmount this degradation challenge
At the same time, clinicians should closely monitor ketone levels, especially during dose adjustments
In November 2023, the Food and Drug Administration approved a version for weight loss under the name Zepbound.
However, despite their benefits, these drugs can be dangerous, carrying an increased risk of severe side effects that can significantly impact a persons health and well-being
Thats kind of scary, and thats the No
